What Makes a Cold Virus Different From an R N a Virus?

Otto Yang, MD, an infectious disease researcher at UCLA, is leading a global clinical trial on COVID-19 sponsored by the NIH. GP, who had COVID-19 in early March, is a part of the study and has gotten to know Yang’s work over the past several months. Today, they talk about the long-tail symptoms of the virus, what scientists have learned about antibodies and immunity, and what is still unknown. Yang answers questions about the vaccine and what we can expect to happen next year. He also shares, from the perspective of a scientist, how he processes fear around this virus. His biggest learning in the last year? It involves the surprising resilience of the human spirit. (For more, see The goop Podcast hub.)

To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy

Learn more about your ad choices. Visit https://podcastchoices.com/adchoices